Acro Biomedical Co Stock Market Value
| ACBM Stock | USD 0.0007 0.00 0.00% |
| Symbol | ACRO |
ACRO Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ACRO Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ACRO Biomedical.
| 04/27/2025 |
| 07/26/2025 |
If you would invest 0.00 in ACRO Biomedical on April 27, 2025 and sell it all today you would earn a total of 0.00 from holding ACRO Biomedical Co or generate 0.0% return on investment in ACRO Biomedical over 90 days. ACRO Biomedical is related to or competes with VitaSpring Biomedical, Acurx Pharmaceuticals, Edgewise Therapeutics, Arch Biopartners, and Covalon Technologies. Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products More
ACRO Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ACRO Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ACRO Biomedical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 30.0 |
ACRO Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ACRO Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ACRO Biomedical's standard deviation. In reality, there are many statistical measures that can use ACRO Biomedical historical prices to predict the future ACRO Biomedical's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | 0.3134 |
ACRO Biomedical Backtested Returns
ACRO Biomedical secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. ACRO Biomedical Co exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ACRO Biomedical's Variance of 14.52, mean deviation of 0.9521, and Coefficient Of Variation of (787.40) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.58, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ACRO Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, ACRO Biomedical is expected to outperform it. At this point, ACRO Biomedical has a negative expected return of -0.48%. Please make sure to confirm ACRO Biomedical's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if ACRO Biomedical performance from the past will be repeated in the future.
Auto-correlation | 0.00 |
No correlation between past and present
ACRO Biomedical Co has no correlation between past and present. Overlapping area represents the amount of predictability between ACRO Biomedical time series from 27th of April 2025 to 11th of June 2025 and 11th of June 2025 to 26th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ACRO Biomedical price movement. The serial correlation of 0.0 indicates that just 0.0% of current ACRO Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ACRO Biomedical lagged returns against current returns
Autocorrelation, which is ACRO Biomedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ACRO Biomedical's pink sheet expected returns. We can calculate the autocorrelation of ACRO Biomedical returns to help us make a trade decision. For example, suppose you find that ACRO Biomedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ACRO Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ACRO Biomedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ACRO Biomedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ACRO Biomedical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
ACRO Biomedical Lagged Returns
When evaluating ACRO Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ACRO Biomedical pink sheet have on its future price. ACRO Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ACRO Biomedical autocorrelation shows the relationship between ACRO Biomedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in ACRO Biomedical Co.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.